BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,037 filers reported holding BAXTER INTL INC in Q1 2015. The put-call ratio across all filers is 0.65 and the average weighting 0.4%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,177,000 | -6.8% | 49,100 | 0.0% | 0.06% | -1.5% |
| Q3 2016 | $2,337,000 | +2.3% | 49,100 | -2.8% | 0.07% | -4.3% |
| Q2 2016 | $2,284,000 | +10.1% | 50,500 | 0.0% | 0.07% | +9.5% |
| Q1 2016 | $2,075,000 | +23.4% | 50,500 | +14.5% | 0.06% | +18.9% |
| Q4 2015 | $1,682,000 | +24.9% | 44,100 | +7.6% | 0.05% | +29.3% |
| Q3 2015 | $1,347,000 | -53.0% | 41,000 | 0.0% | 0.04% | -52.3% |
| Q2 2015 | $2,867,000 | +2.1% | 41,000 | 0.0% | 0.09% | +6.2% |
| Q1 2015 | $2,809,000 | -47.3% | 41,000 | -43.6% | 0.08% | -46.4% |
| Q4 2014 | $5,326,000 | +2.1% | 72,675 | 0.0% | 0.15% | -3.2% |
| Q3 2014 | $5,216,000 | -3.6% | 72,675 | -2.9% | 0.16% | -7.1% |
| Q2 2014 | $5,413,000 | +7.1% | 74,875 | +9.0% | 0.17% | -10.2% |
| Q1 2014 | $5,053,000 | +201.9% | 68,675 | +185.3% | 0.19% | +175.0% |
| Q4 2013 | $1,674,000 | +2.9% | 24,075 | -2.8% | 0.07% | -8.1% |
| Q3 2013 | $1,627,000 | -8.2% | 24,775 | -3.1% | 0.07% | -16.9% |
| Q2 2013 | $1,772,000 | – | 25,575 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |